Cleared Traditional

K152906 - Disposable High Pressure Injector Syringe

K152906 is an FDA 510(k) clearance for Disposable High Pressure Injector Syringe, manufactured by Wuxi Yushou Medical Appliances Co., Ltd.. The device is a Class 2 General Hospital device with product code DXT cleared through the Traditional 510(k) pathway after a 418-day FDA review.

K152906 · Wuxi Yushou Medical Appliances Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2016
Decision
418d
Days
Class 2
Risk

K152906 is an FDA 510(k) clearance for the Disposable High Pressure Injector Syringe. Classified as Injector And Syringe, Angiographic (product code DXT), Class II - Special Controls.

Submitted by Wuxi Yushou Medical Appliances Co., Ltd. (Wuxi, CN). The FDA issued a Cleared decision on November 22, 2016 after a review of 418 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 870.1650 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Wuxi Yushou Medical Appliances Co., Ltd. devices

FDA 510(k) Submission Details - K152906

510(k) Number K152906 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2015
Decision Date November 22, 2016
Days to Decision 418 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
289d slower than avg
Panel avg: 129d · This submission: 418d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXT Device Classification - Class 2, Special Controls

Product Code DXT Injector And Syringe, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

P&L Scientific
Jun Peng

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXT Injector And Syringe, Angiographic

All 178
Devices cleared under the same product code (DXT) and FDA review panel - the closest regulatory comparables to K152906.
DyeVert Plus Contrast Reduction System, DyeVert NG Contrast Reduction System
K171217 · Osprey Medical, Inc. · May 2017
DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring System
K163054 · Osprey Medical, Inc. · Mar 2017
Ecomed Disposable Angiographic Syringes
K162088 · Ecomed Solutions, LLC · Jan 2017
Sunmed Control Syringes
K160190 · Sunny Medical Device (Shenzhen) Co., Ltd. · Nov 2016
MR Syringe Dual Pack for Solaris Injectors
K161471 · Coeur, Inc. · Oct 2016
DyeVert NG Contrast Modulation System
K161505 · Osprey Medical, Inc. · Aug 2016